TherapeuticsMD Inc TXMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:30 PM EST
1.35quote price arrow down-0.02 (-1.46%)
Volume
8,724,431
52 week range
0.85 - 2.75

...

Loading . . .

KEY STATS

  • Open1.39
  • Day High1.41
  • Day Low1.33
  • Prev Close1.37
  • 52 Week High2.75
  • 52 Week High Date02/09/21
  • 52 Week Low0.85
  • 52 Week Low Date04/15/20
  • Market Cap523.57M
  • Shares Out387.83M
  • 10 Day Average Volume18.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.01
  • 1 Year % Change-20.41

RATIOS/PROFITABILITY

  • EPS (TTM)-0.67
  • P/E (TTM)-2.02
  • Fwd P/E (NTM)-3.52
  • EBITDA (MRQ)-154.499M
  • ROE (MRQ)-2,499.18%
  • Revenue (MRQ)64.87M
  • Gross Margin (MRQ)75.37%
  • Net Margin (MRQ)-282.90%
  • Debt To Equity (MRQ)-191.69%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest TherapeuticsMD Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes...
Tommy Thompson J.D.
Chairman
Robert Finizio
Chief Executive Officer
John Milligan IV
President
James D'Arecca
Chief Financial Officer
Adam Miller
Chief Information Officer
Marlan Walker J.D.
General Counsel
Michael Donegan
Vice President - Finance
Address
951 W Yamato Rd Ste 220
Boca Raton, FL
33431-4440
United States